周五，Wolfe Research对诊断公司Veracyte, Inc (NASDAQ:VCYT)的股票进行了首次评级，给予"优于大市"评级，目标价为$50.00。该研究机构强调了Veracyte自2021年以来显著的收入增长和毛利率扩张。据该研究机构称，Veracyte的收入已翻倍，毛利率提高了约500个基点。 该公司有望在本年度实现9000万至1亿美元的调整后EBITDA。Wolfe Rese ...

Tobin Marcus, Wolfe Research policy and politics head, joins CNBC's 'Squawk Box' to discuss what Trump's pick for HHS ...

Wolfe Research has recently raised Warner Bros Discovery Inc (WBD) stock to Peer Perform rating, as announced on November 11, 2024, according to Finviz. Earlier, on August 13, 2024, Bernstein had ...

Fintel reports that on November 14, 2024, Wolfe Research initiated coverage of Repligen (NasdaqGS:RGEN) with a Peer Perform ...

周四，Wolfe Research开始对Maravai LifeSciences Holdings Inc. (NASDAQ:MRVI)的股票进行覆盖，给予同业表现评级。该公司强调了Maravai LifeSciences的几个积极方面，包括其同类最佳的产品、提高客户效率的作用、高比例的耗材收入，以及具有显著改善潜力的可观利润率。 分析师指出，该公司面临的主要挑战在于其大部分收入来自mRNA生物制 ...

Wolfe Research analyst Alexandria Hammond initiated coverage of Johnson & Johnson with an Outperform rating and $190 price target ...

Investing.com - Wolfe Research has upgraded shares of Warner Bros. Discovery (NASDAQ:WBD) to Peer Perform from Underperform following its Q3 results last week, and assigned a fair value range of $ ...

Wolfe Research downgraded Alnylam (ALNY) to Underperform from Peer Perform with a $205 price target The firm cites expectations that the company will expand its approved Amvuttra into the much ...

Wolfe Research has upgraded Warner Bros. Discovery (WBD, Financials) to "peer perform" from "underperform," citing a balanced risk/reward outlook despite Warner Bros. Discoverys $40 billion in ...

Wolfe Research upgraded Warner Bros. Discovery (NASDAQ:WBD) to "peer perform" from "under perform," seeing a balanced risk/reward opportunity even with the $40B in gross debt for the company.

Wolfe Research：上调Dover(DOV.US)评级，由Peer Perform调整至优于大市评级, 目标价227.00美元。 都福集团（DOV.US）公司简介：美国都福集团从事设备 ...

Wolfe Research：下调Honeywell Intl(HON.US)评级，由优于大市调整至Peer Perform评级。 霍尼韦尔（HON.US）公司简介：霍尼韦尔国际有限公司是一家软件工业公司 ...